Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SSS-NX (Serum Substitute Supplement-NX)

K-Number: K233764 · 2024-04-24

Decision Date2024-04-24
Product CodeMQL
Advisory CommitteeOB
DecisionSubstantially Equivalent

Device Summary

SSS-NX (Serum Substitute Supplement-NX) is a medical device manufactured by Fujifilm Irvine Scientific. It received FDA 510(k) clearance on 2024-04-24 under approval number K233764. The device is classified under product code MQL. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SSS-NX (Serum Substitute Supplement-NX)?

SSS-NX (Serum Substitute Supplement-NX) is a medical device that received FDA 510(k) clearance on 2024-04-24. It is manufactured by Fujifilm Irvine Scientific. The 510(k) number is K233764.

When was SSS-NX (Serum Substitute Supplement-NX) approved by the FDA?

SSS-NX (Serum Substitute Supplement-NX) received FDA 510(k) clearance on 2024-04-24, under approval number K233764.

What company makes SSS-NX (Serum Substitute Supplement-NX)?

SSS-NX (Serum Substitute Supplement-NX) is manufactured by Fujifilm Irvine Scientific.

What is the FDA product code for SSS-NX (Serum Substitute Supplement-NX)?

The FDA product code for SSS-NX (Serum Substitute Supplement-NX) is MQL.

Other Devices by Fujifilm Irvine Scientific

Related Devices (Code: MQL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.